Table 5.
Common lncRNA expression changes in healthy ASM cells after treatment with FCS or Dex + FCS
| |
|
|
FCS |
Dex + FCS |
|---|---|---|---|---|
| Class of lncRNA | Ensemble gene ID | Transcript | Microarray (FC) | Microarray (FC) |
| Known sense overlapping |
ENST00000314957 |
CTD-2201E18.3 |
−1.73 (<.01) |
1.78 (<.05) |
| lincRNA |
ENST00000414120 |
LINC00887 |
−1.81 (<.05) |
−1.93 (<.01) |
| Known antisense |
ENST00000415647 |
RP11-46A10.4 |
−1.62 (<.05) |
−1.65 (<.05) |
| lincRNA |
ENST00000417485 |
AC012668.2 |
−2.28 (<.01) |
−1.81 (<.01) |
| lincRNA |
ENST00000418539 |
BCYRN1 |
−1.53 (<.05) |
2.37 (<.05) |
| Known antisense |
ENST00000420095 |
LMCD1-AS1 |
−1.57 (<.05) |
5.65 (<.05) |
| lincRNA |
ENST00000426635 |
LINC00472 |
1.86 (<.05) |
2.64 (<.05) |
| lincRNA |
ENST00000431759 |
SLC2A1-AS1 |
−1.95 (<.05) |
−2.09 (<.05) |
| lincRNA |
ENST00000433843 |
SNHG5 |
−1.74 (<.05) |
−1.51 (<.01) |
| lincRNA |
ENST00000442316 |
AC074363.1 |
−1.60 (<.05) |
−1.62 (<.05) |
| lincRNA |
ENST00000444958 |
DANCR |
2.59 (<.05) |
2.38 (<.05) |
| Known antisense |
ENST00000446423 |
SDCBP2 |
−1.82 (<.05) |
−1.82 (<.05) |
| lincRNA |
ENST00000448738 |
RP1-295F6.2 |
1.62 (<.05) |
1.53 (<.05) |
| lincRNA |
ENST00000451910 |
RP11-344J7.2 |
2.06 (<.01) |
1.66 (<.05) |
| Known retained intron |
ENST00000453698 |
SNHG11 |
−2.85 (<.01) |
−2.24 (<.01) |
| lincRNA |
ENST00000473636 |
LINC00882 |
2.14 (<.05) |
2.08 (<.05) |
| lincRNA |
ENST00000495228 |
LINC00883 |
1.63 (<.05) |
1.78 (<.05) |
| lincRNA |
ENST00000505448 |
RP11-774O3.3 |
−1.57 (<.001) |
−1.66 (<.05) |
| Known antisense |
ENST00000507963 |
NR2F1-AS1 |
−1.66 (<.05) |
−1.61 (<.05) |
| Known antisense |
ENST00000509179 |
MEF2C-AS1 |
−2.59 (<.05) |
−2.16 (<.01) |
| lincRNA |
ENST00000515296 |
CTB-35F21.1 |
−1.83 (<.05) |
−1.94 (<.05) |
| lincRNA |
ENST00000515306 |
CTB-35F21.2 |
−2.23 (<.05) |
−2.15 (<.05) |
| lincRNA |
ENST00000515871 |
CTC-325J23.3 |
1.60 (<.05) |
1.72 (<.01) |
| lincRNA |
ENST00000518765 |
RP11-527N22.1 |
−1.69 (<.05) |
−1.53 (<.05) |
| lincRNA |
ENST00000518771 |
RP11-37B2.1 |
−1.85 (<.001) |
−1.71 (<.001) |
| lincRNA |
ENST00000521128 |
CTB-43E15.3 |
−2.07 (<.05) |
−2.06 (<.05) |
| lincRNA |
ENST00000523242 |
CTB-43E15.1 |
−1.79 (<.05) |
−2.02 (<.05) |
| lincRNA |
ENST00000523328 |
PVT1 |
1.39 (<.01) |
1.66 (<.001) |
| lincRNA | ENST00000538996 | AP003486.1 | −2.69 (<.01) | −1.81 (<.05) |
This table lists those lncRNAs that have been manually annotated in the Ensembl database and the expression of which is significantly changed in healthy ASM cells after stimulation with FCS (2.5%) or treatment with dexamethasone (10−7 M) before stimulation with FCS (2.5%). Microarray data are denoted as the fold change against baseline control and is the mean of 9 individual patients. These values are for those genes that demonstrated an FDR of less than 0.05; associated P values are shown.